Eye doctors in low-resource countries will receive sophisticated diagnostic technology thanks to a new collaboration between Orbis International, a nonprofit organization fighting global blindness, and Visulytix, an artificial intelligence (AI) company applying AI-powered software to ophthalmology.
This new technology, called Pegasus, aids physicians with the detection and diagnosis of serious eye diseases such as diabetic retinopathy, age-related macular degeneration, and glaucoma. Eye doctors in these low-resource countries will be among the first in the world to have free access to this innovative service through Cybersight, Orbis’ telemedicine platform.
Cybersight enables physicians to request a second opinion on complex cases from Orbis’ network of international ophthalmology experts. This service has enabled medical professionals to help 18,000 patients to date, and the addition of Visulytix’s Pegasus AI system means these doctors will now have access to the latest advancements in medical AI to help them detect, diagnose, and treat patients with blinding eye diseases. Specifically, the Pegasus AI system analyzes images of the back of the eye taken with any standard retina camera—or even mobile phones. Images are sent seamlessly through Cybersight to Visulytix’s cloud service, and the AI system returns a report to Cybersight in just 8 seconds with analysis.
Currently, an estimated 253 million people are suffering from visual impairment or blindness, and yet, 75% of all visual impairment can be prevented or treated with access to effective care.